Origin Therapeutics Holdings (XCNQ:ORIG) Long-Term Debt : C$0.00 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Long-Term Debt?

Origin Therapeutics Holdings's Long-Term Debt for the quarter that ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings Long-Term Debt Historical Data

The historical data trend for Origin Therapeutics Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Long-Term Debt Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Long-Term Debt

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Long-Term Debt	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings (XCNQ:ORIG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Origin Therapeutics Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.